What it is
A once-daily GLP-1 receptor agonist administered by subcutaneous injection.
How it works
Activates GLP-1 receptors, augmenting glucose-dependent insulin release, suppressing glucagon, slowing gastric emptying, and reducing appetite.
Where it's used
Used in type 2 diabetes (Victoza) and chronic weight management (Saxenda).
FDA-approved use
Type 2 diabetes (Victoza, adults and pediatric patients aged 10+); chronic weight management (Saxenda).
Tracking it
Liraglutide is injectable, so two things matter in a log: when you dosed and where. Rotating sites and writing both down prevents the classic “did I already pin the left side?” problem. with a half-life of about 13 hours, a dose log also lets a tracker model the relative amount still in your system between doses. for titrated compounds like this one, a log that records the dose at each step is the difference between knowing your history and guessing it.
Source
OpenFDA
Last reviewed 2026-06-11